基于生物信息学分析的牙周炎和阿尔茨海默病的潜在诊断标志物和治疗点
Kai Yang1, Zhaoqi Zhang2, Qingyuan Zhang2
1Acupuncture and Moxibustion Massage College, Shandong University of Traditional Chinese Medicine, Jinan, China.
Journal of periodontal research
|January 8, 2024
概括
这项研究确定了牙周炎和阿尔茨海默病 (AD) 中常见的基因和免疫细胞变化,揭示了这些相互关联的炎症状况的潜在治疗点.
科学领域:
- 基因组学和生物信息学
- 免疫学 免疫学 免疫学
- 神经科学是一个神经科学.
背景情况:
- 牙周炎是一种影响口腔健康的慢性炎症性疾病.
- 牙周炎越来越被认为是阿尔茨海默病 (AD) 的危险因素.
- 了解牙周炎和AD之间的共同遗传和机制联系至关重要,但不完整.
研究的目的:
- 为了确定牙周炎和AD之间共享的共同基因.
- 在两种疾病中分析关键基因和免疫细胞之间的关系.
- 发现AD复杂的牙周炎的新型治疗点.
主要方法:
- 对牙周炎和AD的差异基因表达分析.
- 使用GEO数据库数据识别共同表达的基因.
- 使用STRING和其他算法构建蛋白质-蛋白质相互作用网络并识别枢纽基因.
- 评估基因与免疫细胞的关联以及潜在的药物点.
主要成果:
- 他们发现了六个关键的共同基因 (PDGFRB,VCAN,TIMP1,CHL1,EFEMP2,IGFBP5).
- 在牙周炎和AD患者中,自然杀手细胞和骨髓细胞衍生的抑制细胞的显著差异表达.
- 确定FOXC1和GATA2是关键的转录因子;与这两种疾病相关的特定微RNA (miR-23a/b).
- 枢纽基因表明潜在的药物向相互作用.
结论:
- 这项研究强调了共享的枢纽基因和牙周炎和AD之间的免疫透模式.
- 鉴定的基因和免疫细胞协会为治疗策略提供了新的视角.
- 这些发现可能有助于制定与AD同时发生的牙周炎的治疗方法.
更多相关视频
相关概念视频
Alzheimer's Disease: Overview
490
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
490
Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195


